Article ID Journal Published Year Pages File Type
6115470 Diagnostic Microbiology and Infectious Disease 2015 18 Pages PDF
Abstract
The association between varying durations of previous vancomycin therapy and subsequent daptomycin success rates was evaluated in a subset of patients with methicillin-resistant Staphylococcus aureus bacteremia from the Cubicin® Outcomes Registry and Experience 2005-2009 (n = 159). Previous vancomycin exposure did not adversely affect daptomycin outcomes; success rates were 81% in patients treated with first-line daptomycin and 89%, 83%, and 88%, respectively, in patients with 1-3 days, 4-6 days, and ≥7 days of previous vancomycin exposure (P = 0.5).
Related Topics
Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology
Authors
, , , ,